1. Home
  2. MDWD vs OGI Comparison

MDWD vs OGI Comparison

Compare MDWD & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$19.37

Market Cap

238.5M

Sector

Health Care

ML Signal

HOLD

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

HOLD

Current Price

$1.68

Market Cap

218.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDWD
OGI
Founded
2000
2013
Country
Israel
Canada
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.5M
218.5M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
MDWD
OGI
Price
$19.37
$1.68
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$37.50
N/A
AVG Volume (30 Days)
83.1K
1.9M
Earning Date
11-20-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,932,000.00
$186,075,713.00
Revenue This Year
$15.89
$20.38
Revenue Next Year
$25.33
$6.02
P/E Ratio
N/A
N/A
Revenue Growth
6.15
N/A
52 Week Low
$14.14
$0.85
52 Week High
$22.51
$2.24

Technical Indicators

Market Signals
Indicator
MDWD
OGI
Relative Strength Index (RSI) 61.17 46.44
Support Level $18.55 $1.67
Resistance Level $18.86 $1.76
Average True Range (ATR) 0.56 0.13
MACD 0.01 -0.03
Stochastic Oscillator 83.70 13.28

Price Performance

Historical Comparison
MDWD
OGI

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Share on Social Networks: